Small-cell lung cancer
CM Rudin, E Brambilla, C Faivre-Finn… - Nature Reviews Disease …, 2021 - nature.com
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
Mechanisms of small cell lung cancer metastasis
J Ko, MM Winslow, J Sage - EMBO molecular medicine, 2021 - embopress.org
Metastasis is a major cause of morbidity and mortality in cancer patients. However, the
molecular and cellular mechanisms underlying the ability of cancer cells to metastasize …
molecular and cellular mechanisms underlying the ability of cancer cells to metastasize …
[HTML][HTML] Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Small cell lung cancer (SCLC) is an aggressive malignancy that includes subtypes defined
by differential expression of ASCL1, NEUROD1, and POU2F3 (SCLC-A,-N, and-P …
by differential expression of ASCL1, NEUROD1, and POU2F3 (SCLC-A,-N, and-P …
[HTML][HTML] SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization
MK Baine, MS Hsieh, WV Lai, JV Egger… - Journal of Thoracic …, 2020 - Elsevier
Introduction Recent studies have identified subtypes of small cell lung carcinoma (SCLC)
defined by the RNA expression of ASCL1, NEUROD1, POU2F3, and YAP1 transcriptional …
defined by the RNA expression of ASCL1, NEUROD1, POU2F3, and YAP1 transcriptional …
[HTML][HTML] cfDNA methylome profiling for detection and subtyping of small cell lung cancers
Small cell lung cancer (SCLC) is characterized by morphologic, epigenetic and
transcriptomic heterogeneity. Subtypes based upon predominant transcription factor …
transcriptomic heterogeneity. Subtypes based upon predominant transcription factor …
[HTML][HTML] Binary pan-cancer classes with distinct vulnerabilities defined by pro-or anti-cancer YAP/TEAD activity
JD Pearson, K Huang, M Pacal, SR McCurdy, S Lu… - Cancer Cell, 2021 - cell.com
Cancer heterogeneity impacts therapeutic response, driving efforts to discover over-arching
rules that supersede variability. Here, we define pan-cancer binary classes based on distinct …
rules that supersede variability. Here, we define pan-cancer binary classes based on distinct …
[HTML][HTML] A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates
We present a multiomic cell atlas of human lung development that combines single-cell RNA
and ATAC sequencing, high-throughput spatial transcriptomics, and single-cell imaging …
and ATAC sequencing, high-throughput spatial transcriptomics, and single-cell imaging …
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Small cell lung cancer (SCLC) exists broadly in four molecular subtypes: ASCL1,
NEUROD1, POU2F3 and Inflammatory. Initially, SCLC subtypes were thought to be mutually …
NEUROD1, POU2F3 and Inflammatory. Initially, SCLC subtypes were thought to be mutually …
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
T Li, T Qiao - Seminars in cancer biology, 2022 - Elsevier
Small-cell lung cancer (SCLC) is an aggressive lung cancer subtype and its first-line
treatment has remained unchanged for decades. In recent years, immunotherapy has …
treatment has remained unchanged for decades. In recent years, immunotherapy has …
The transcriptional and epigenetic landscape of cancer cell lineage plasticity
Lineage plasticity, a process whereby cells change their phenotype to take on a different
molecular and/or histologic identity, is a key driver of cancer progression and therapy …
molecular and/or histologic identity, is a key driver of cancer progression and therapy …